Replies to post #188021 on Biotech Values

[DewDiligence]

OHRP/OPHT—When you look at “classic” only patients squalamine outperformed fovista.

The categorization of wet AMD as classic or occult is a carryover from the days of Visudyne photodynamic therapy; this characterization has not been shown to have relevance to treatment with anti-VEGF agents.

[DewDiligence]

p.s. You should have disclosed that you have a business relationship with OHRP. Readers of this board have a right to know such things.

[DFRAI]

DRbio

How many letter improvement was noticed....there seem to be treatments in the pipeline with improvement of 7-12 letters

Is it worth investment dollars here?